JP2010510260A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510260A5
JP2010510260A5 JP2009537507A JP2009537507A JP2010510260A5 JP 2010510260 A5 JP2010510260 A5 JP 2010510260A5 JP 2009537507 A JP2009537507 A JP 2009537507A JP 2009537507 A JP2009537507 A JP 2009537507A JP 2010510260 A5 JP2010510260 A5 JP 2010510260A5
Authority
JP
Japan
Prior art keywords
skin
layer
transdermal therapeutic
therapeutic system
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009537507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510260A (ja
JP5881935B2 (ja
Filing date
Publication date
Priority claimed from DE102006054733A external-priority patent/DE102006054733A1/de
Application filed filed Critical
Publication of JP2010510260A publication Critical patent/JP2010510260A/ja
Publication of JP2010510260A5 publication Critical patent/JP2010510260A5/ja
Application granted granted Critical
Publication of JP5881935B2 publication Critical patent/JP5881935B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009537507A 2006-11-21 2007-11-09 活性物質の利用率及び用量精度の高い経皮治療システム Expired - Fee Related JP5881935B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006054733.0 2006-11-21
DE102006054733A DE102006054733A1 (de) 2006-11-21 2006-11-21 Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
PCT/EP2007/009707 WO2008061639A1 (de) 2006-11-21 2007-11-09 Transdermales therapeutisches system mit hoher wirkstoffausnutzungsrate und dosiergenauigkeit

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015229478A Division JP6109280B2 (ja) 2006-11-21 2015-11-25 活性物質の利用率及び用量精度の高い経皮治療システム

Publications (3)

Publication Number Publication Date
JP2010510260A JP2010510260A (ja) 2010-04-02
JP2010510260A5 true JP2010510260A5 (enExample) 2013-07-04
JP5881935B2 JP5881935B2 (ja) 2016-03-09

Family

ID=39060261

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009537507A Expired - Fee Related JP5881935B2 (ja) 2006-11-21 2007-11-09 活性物質の利用率及び用量精度の高い経皮治療システム
JP2015229478A Active JP6109280B2 (ja) 2006-11-21 2015-11-25 活性物質の利用率及び用量精度の高い経皮治療システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015229478A Active JP6109280B2 (ja) 2006-11-21 2015-11-25 活性物質の利用率及び用量精度の高い経皮治療システム

Country Status (16)

Country Link
US (3) US9056026B2 (enExample)
EP (1) EP2094213B1 (enExample)
JP (2) JP5881935B2 (enExample)
KR (1) KR101471216B1 (enExample)
CN (1) CN101522146B (enExample)
AU (1) AU2007323401C1 (enExample)
BR (1) BRPI0719006B8 (enExample)
CA (1) CA2662510C (enExample)
DE (1) DE102006054733A1 (enExample)
ES (1) ES2549692T3 (enExample)
IL (1) IL198714A0 (enExample)
MX (1) MX2009005343A (enExample)
NZ (1) NZ575043A (enExample)
RU (1) RU2454994C2 (enExample)
WO (1) WO2008061639A1 (enExample)
ZA (1) ZA200902579B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
DE102011114411A1 (de) * 2011-09-26 2013-03-28 Lts Lohmann Therapie-Systeme Ag Pflaster mit einstellbarer Okklusion
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
CN105358139B (zh) 2013-07-03 2020-10-16 Lts罗曼治疗方法有限公司 具有电子元件的经皮治疗系统
ES2954087T3 (es) 2014-05-20 2023-11-20 Lts Lohmann Therapie Systeme Ag Sistema de administración transdérmica que incluye un mediador de interfase
CA2948220C (en) 2014-05-20 2023-06-20 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system containing rotigotine
CN106456567A (zh) 2014-05-20 2017-02-22 Lts勒曼治疗系统股份公司 在经皮递送系统中调节活性剂释放的方法
EP3233081B1 (en) * 2014-12-19 2021-09-22 Kindeva Drug Delivery L.P. Transdermal drug delivery device including fentanyl
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. 薬剤送達方法及びシステム
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US20210393607A1 (en) * 2018-11-09 2021-12-23 Medrx Co., Ltd. Transdermal Patch Containing Fentanyl as Active Ingredient
WO2020102695A1 (en) 2018-11-16 2020-05-22 Cti (Assignment For Benefit Of Creditors) Llc Thermally regulated transdermal drug delivery system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5240711A (en) 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
JPH1036265A (ja) 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
KR100885235B1 (ko) 1998-12-07 2009-02-24 엘란 파마 인터내셔널 리미티드 휘발성 액상 약물 전달을 위한 경피성 패취
DE10012908B4 (de) 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10054479A1 (de) * 2000-11-03 2002-05-08 Henkel Kgaa Kosmetische Pflaster zur Hautaufhellung
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE10103860B4 (de) 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
DE10110391A1 (de) * 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DK1455893T3 (da) * 2001-12-20 2007-04-02 Alza Corp Elektrotransportindretning med et integralt stöbt reservoirhus
JP2003300873A (ja) * 2002-04-12 2003-10-21 Nitto Denko Corp 貼付剤およびその製造方法
AR033748A1 (es) 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
DE102004003224A1 (de) * 2003-02-07 2004-08-26 Lts Lohmann Therapie-Systeme Ag Für die Wärmeanwendung zur Beschleunigung der Permeation von Wirkstoffen geeignetes transdermales System und seine Verwendung
JP2006517124A (ja) 2003-02-07 2006-07-20 エルテーエス ローマン テラピー−ジステーメ アーゲー 活性物質の浸透を促進するために熱を用いるのに適した経皮治療システム及びその使用
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US20050202073A1 (en) * 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
WO2006044206A2 (en) * 2004-10-08 2006-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
DE102005011517A1 (de) 2005-03-10 2006-09-21 Grünenthal GmbH Transdermales therapeutisches System zur Verabreichung von Analgetika
DE102006026060B4 (de) 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System enthaltend als Wirkstoff Nikotin und Verfahren zur Herstellung solcher Systeme
US20070298961A1 (en) 2006-06-22 2007-12-27 Rice Gordon L Method of producing electrodes
DE102006054733A1 (de) * 2006-11-21 2008-05-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit

Similar Documents

Publication Publication Date Title
JP2010510260A5 (enExample)
JP6109280B2 (ja) 活性物質の利用率及び用量精度の高い経皮治療システム
CN104144684B (zh) 含有多奈哌齐的经皮吸收制剂及其制备方法
KR101685736B1 (ko) 중합체 필름 내 약제의 결정화를 방지하는 방법
JP2016502989A5 (enExample)
CZ20032813A3 (cs) Transdermální náplast pro podání fentanylu
JP2016504368A5 (enExample)
JP7072520B2 (ja) 二重ディスク経皮システム
JP2011527697A5 (enExample)
KR20160108831A (ko) 남용 및 오용 저지 경피 시스템
US20140105979A1 (en) Compositions and methods for the transdermal delivery of methylphenidate
CN106659702A (zh) 透皮递送体系
KR101583680B1 (ko) 펜타닐의 1일-1회 교체 경피 투여
JP2011500604A5 (enExample)
JP6832287B2 (ja) 2層の接着層を含むオーバーテープを用いる経皮治療システム
CA2513402A1 (en) Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
JP5954919B2 (ja) 揮発性および/または熱不安定性物質用の経皮吸収治療システム
JP2007513916A (ja) 架橋親水性重合体を基礎とする投与剤形
ZA200505629B (en) Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances and the use thereof
HK1132898A (en) Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
JPWO2021078761A5 (enExample)
JPS61251618A (ja) 外用医薬部材